Literature DB >> 26459361

Cognition and Depression Following Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus Pars Internus in Parkinson's Disease: A Meta-Analysis.

Hannah L Combs1, Bradley S Folley2,3, David T R Berry4, Suzanne C Segerstrom5, Dong Y Han6, Amelia J Anderson-Mooney7, Brittany D Walls8, Craig van Horne9.   

Abstract

Parkinson's disease (PD) is a common, degenerative disorder of the central nervous system. Individuals experience predominantly extrapyramidal symptoms including resting tremor, rigidity, bradykinesia, gait abnormalities, cognitive impairment, depression, and neurobehavioral concerns. Cognitive impairments associated with PD are diverse, including difficulty with attention, processing speed, executive functioning, memory recall, visuospatial functions, word-retrieval, and naming. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) or globus pallidus internus (GPi) is FDA approved and has been shown to be effective in reducing motor symptoms of PD. Studies have found that stimulating STN and GPi are equally effective at improving motor symptoms and dyskinesias; however, there has been discrepancy as to whether the cognitive, behavioral, and mood symptoms are affected differently between the two targets. The present study used random-effects meta-analytic models along with a novel p-curve analytic procedure to compare the potential cognitive and emotional impairments associated with STN-DBS in the current literature to those associated with GPi-DBS. Forty-one articles were reviewed with an aggregated sample size of 1622 patients. Following STN-DBS, small declines were found in psychomotor speed, memory, attention, executive functions, and overall cognition; and moderate declines were found in both semantic and phonemic fluency. However, GPi-DBS resulted in fewer neurocognitive declines than STN-DBS (small declines in attention and small-moderate declines in verbal fluency). With regards to its effect on depression symptomatology, both GPi-DBS and STN-DBS resulted in lower levels of depressive symptoms post-surgery. From a neurocognitive standpoint, both GPi-DBS and STN-DBS produce subtle cognitive declines but appears to be relatively well tolerated.

Entities:  

Keywords:  Cognition; Deep brain stimulation; Pallidal; Parkinson’s disease; Subthalamic

Mesh:

Year:  2015        PMID: 26459361     DOI: 10.1007/s11065-015-9302-0

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  55 in total

1.  Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease.

Authors:  B Pillon; C Ardouin; P Damier; P Krack; J L Houeto; H Klinger; A M Bonnet; P Pollak; A L Benabid; Y Agid
Journal:  Neurology       Date:  2000-08-08       Impact factor: 9.910

2.  Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits.

Authors:  L Castelli; P Perozzo; M Zibetti; B Crivelli; U Morabito; M Lanotte; F Cossa; B Bergamasco; L Lopiano
Journal:  Eur Neurol       Date:  2006-05-08       Impact factor: 1.710

3.  Psychiatric disturbances in Parkinson's disease.

Authors:  G G Celesia; W M Wanamaker
Journal:  Dis Nerv Syst       Date:  1972-09

4.  Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease.

Authors:  Aurélie Funkiewiez; Claire Ardouin; Roshan Cools; Paul Krack; Valérie Fraix; Alina Batir; Stephan Chabardès; Alim-Louis Benabid; Trevor W Robbins; Pierre Pollak
Journal:  Mov Disord       Date:  2006-10       Impact factor: 10.338

5.  Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.

Authors:  Valerie C Anderson; Kim J Burchiel; Penelope Hogarth; Jacques Favre; John P Hammerstad
Journal:  Arch Neurol       Date:  2005-04

6.  Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years.

Authors:  H Russmann; J Ghika; J-G Villemure; B Robert; J Bogousslavsky; P R Burkhard; F J G Vingerhoets
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

7.  Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.

Authors:  Kenneth A Follett; Frances M Weaver; Matthew Stern; Kwan Hur; Crystal L Harris; Ping Luo; William J Marks; Johannes Rothlind; Oren Sagher; Claudia Moy; Rajesh Pahwa; Kim Burchiel; Penelope Hogarth; Eugene C Lai; John E Duda; Kathryn Holloway; Ali Samii; Stacy Horn; Jeff M Bronstein; Gatana Stoner; Philip A Starr; Richard Simpson; Gordon Baltuch; Antonio De Salles; Grant D Huang; Domenic J Reda
Journal:  N Engl J Med       Date:  2010-06-03       Impact factor: 91.245

8.  Depression in Parkinson's disease.

Authors:  S E Starkstein; T J Preziosi; P L Bolduc; R G Robinson
Journal:  J Nerv Ment Dis       Date:  1990-01       Impact factor: 2.254

9.  Deep brain stimulation of the subthalamic nucleus and cognitive functions in Parkinson's disease.

Authors:  O Klempírová; R Jech; D Urgosík; J Klempír; N Spacková; J Roth; E Růzicka
Journal:  Prague Med Rep       Date:  2007

10.  Neuropsychological effects after chronic subthalamic stimulation and the topography of the nucleus in Parkinson's disease.

Authors:  Sheng-Tzung Tsai; Sheng-Huang Lin; Shinn-Zong Lin; Jen-Yeu Chen; Chi-Wei Lee; Shin-Yuan Chen
Journal:  Neurosurgery       Date:  2007-11       Impact factor: 4.654

View more
  51 in total

1.  White matter tracts lesions and decline of verbal fluency after deep brain stimulation in Parkinson's disease.

Authors:  Guillaume Costentin; Stéphane Derrey; Emmanuel Gérardin; Yohann Cruypeninck; Thibaut Pressat-Laffouilhere; Youssef Anouar; David Wallon; Floriane Le Goff; Marie-Laure Welter; David Maltête
Journal:  Hum Brain Mapp       Date:  2019-02-18       Impact factor: 5.038

Review 2.  Effects of Subthalamic Nucleus Deep Brain Stimulation on Facial Emotion Recognition in Parkinson's Disease: A Critical Literature Review.

Authors:  S Kalampokini; E Lyros; P Lochner; K Fassbender; M M Unger
Journal:  Behav Neurol       Date:  2020-07-17       Impact factor: 3.342

3.  No differences in neuropsychological outcomes between constant current and voltage current subthalamic deep brain stimulation for Parkinson's disease.

Authors:  Michele K York; Elena Moro
Journal:  Ann Transl Med       Date:  2017-04

4.  Neuropsychological outcomes from deep brain stimulation-stimulation versus micro-lesion.

Authors:  Tammy Pham; Jeff M Bronstein
Journal:  Ann Transl Med       Date:  2017-05

5.  Hemispheric Asymmetry of Globus Pallidus Relates to Alpha Modulation in Reward-Related Attentional Tasks.

Authors:  Cecilia Mazzetti; Tobias Staudigl; Tom R Marshall; Johanna M Zumer; Sean J Fallon; Ole Jensen
Journal:  J Neurosci       Date:  2019-10-02       Impact factor: 6.167

Review 6.  Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: A Meta-Analysis of Mood Effects.

Authors:  Tomas Cartmill; David Skvarc; Richard Bittar; Jane McGillivray; Michael Berk; Linda K Byrne
Journal:  Neuropsychol Rev       Date:  2021-02-19       Impact factor: 7.444

7.  Cognitive Impact of Deep Brain Stimulation in Parkinson's Disease Patients: A Systematic Review.

Authors:  Valentino Rački; Mario Hero; Gloria Rožmarić; Eliša Papić; Marina Raguž; Darko Chudy; Vladimira Vuletić
Journal:  Front Hum Neurosci       Date:  2022-05-13       Impact factor: 3.473

Review 8.  Current Practice and the Future of Deep Brain Stimulation Therapy in Parkinson's Disease.

Authors:  Leonardo Almeida; Wissam Deeb; Chauncey Spears; Enrico Opri; Rene Molina; Daniel Martinez-Ramirez; Aysegul Gunduz; Christopher W Hess; Michael S Okun
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

9.  Longterm outcome of cognition, affective state, and quality of life following subthalamic deep brain stimulation in Parkinson's disease.

Authors:  Doreen Gruber; Lisa Calmbach; Andrea A Kühn; Patricia Krause; Ute A Kopp; Gerd-Helge Schneider; Andreas Kupsch
Journal:  J Neural Transm (Vienna)       Date:  2019-01-25       Impact factor: 3.575

10.  Association of MRI Measurements with Cognitive Outcomes After STN-DBS in Parkinson's Disease.

Authors:  Laura J Weinkle; Brian Hoyt; John A Thompson; Stefan Sillau; Jody Tanabe; Justin Honce; Olga Klepitskaya
Journal:  Mov Disord Clin Pract       Date:  2018-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.